{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T15:04:16Z","timestamp":1792854256593,"version":"4.5.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1007\/s40266-017-0498-y","type":"journal-article","created":{"date-parts":[[2017,11,23]],"date-time":"2017-11-23T08:42:30Z","timestamp":1511426550000},"page":"859-868","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Risk of Malignancy in a Nationwide Cohort of Elderly Inflammatory Bowel Disease Patients"],"prefix":"10.1007","volume":"34","author":[{"given":"Nabeel","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Vallarino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor","family":"Lissoos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1487-2286","authenticated-orcid":false,"given":"Umar","family":"Darr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,23]]},"reference":[{"key":"498_CR1","unstructured":"The Facts About Inflammatory Bowel Diseases. Crohn\u2019s and Colitis Foundation of America. http:\/\/www.ccfa.org\/assets\/pdfs\/updatedibdfactbook.pdf . Accessed Apr 2017."},{"issue":"1","key":"498_CR2","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1053\/j.gastro.2011.10.001","volume":"142","author":"NA Molodecky","year":"2012","unstructured":"Molodecky NA, Soon S, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142(1):46\u201354.","journal-title":"Gastroenterology"},{"issue":"3","key":"498_CR3","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s11938-016-0099-6","volume":"14","author":"ES John","year":"2016","unstructured":"John ES, Katz K, Saxena M, et al. Management of inflammatory bowel disease in the elderly. Curr Treat Options Gastroenterol. 2016;14(3):285\u2013304.","journal-title":"Curr Treat Options Gastroenterol"},{"issue":"11","key":"498_CR4","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1038\/ajg.2011.271","volume":"106","author":"S Katz","year":"2011","unstructured":"Katz S, Pardi DS. Inflammatory bowel disease of the elderly: frequently asked questions (FAQs). Am J Gastroenterol. 2011;106(11):1889\u201397.","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"498_CR5","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1136\/gutjnl-2012-303864","volume":"63","author":"C Charpentier","year":"2014","unstructured":"Charpentier C, Salleron J, Savoye G, et al. Natural history of elderly-onset inflammatory bowel disease: a population-based cohort study. Gut. 2014;63(3):423\u201332.","journal-title":"Gut"},{"issue":"9","key":"498_CR6","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1007\/s10620-012-2083-x","volume":"57","author":"M Juneja","year":"2012","unstructured":"Juneja M, Baidoo L, Schwartz MB, et al. Geriatric inflammatory bowel disease: phenotypic presentation, treatment patterns, nutritional status, outcomes, and comorbidity. Dig Dis Sci. 2012;57(9):2408\u201315.","journal-title":"Dig Dis Sci"},{"issue":"9","key":"498_CR7","doi-asserted-by":"crossref","first-page":"e008597","DOI":"10.1136\/bmjopen-2015-008597","volume":"5","author":"SL Johnson","year":"2015","unstructured":"Johnson SL, Bartels CM, Palta M, et al. Biological and steroid use in relationship to quality measures in older patients with inflammatory bowel disease: a US Medicare cohort study. BMJ Open. 2015;5(9):e008597.","journal-title":"BMJ Open"},{"issue":"3","key":"498_CR8","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.crohns.2011.02.001","volume":"5","author":"A Stallmach","year":"2011","unstructured":"Stallmach A, Hagel S, Gharbi A, et al. Medical and surgical therapy of inflammatory bowel disease in the elderly\u2014prospects and complications. J Crohn\u2019s Colitis. 2011;5(3):177\u201388.","journal-title":"J Crohn\u2019s Colitis."},{"issue":"6","key":"498_CR9","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/ecco-jcc\/jjv059","volume":"9","author":"S Taleban","year":"2015","unstructured":"Taleban S, Colombel JF, Mohler MJ, et al. Inflammatory bowel disease and the elderly: a review. J Crohn\u2019s Colitis. 2015;9(6):507\u201315.","journal-title":"J Crohn\u2019s Colitis"},{"issue":"5","key":"498_CR10","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s10552-007-0131-1","volume":"18","author":"S Setoguchi","year":"2007","unstructured":"Setoguchi S, Solomon DH, Glynn RJ, et al. Agreement of diagnosis and its date for hematologic malignancies and solid tumors between Medicare claims and cancer registry data. Cancer Causes Control. 2007;18(5):561\u20139.","journal-title":"Cancer Causes Control"},{"key":"498_CR11","unstructured":"Howlader N, Noone AM, Krapcho M, Miller D, Bishop K, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975\u20132014, National Cancer Institute. Bethesda, MD. https:\/\/seer.cancer.gov\/csr\/1975_2014\/ , based on November 2016 SEER data submission, posted to the SEER web site, April 2017."},{"issue":"4","key":"498_CR12","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.amjopharm.2007.12.002","volume":"5","author":"ER Hajjar","year":"2007","unstructured":"Hajjar ER, Cafiero AC, Hanlon JT. Polypharmacy in elderly patients. Am J Geriatr Pharmacother. 2007;5(4):345\u201351.","journal-title":"Am J Geriatr Pharmacother"},{"issue":"2","key":"498_CR13","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/ajg.2008.168","volume":"104","author":"GR Lichtenstein","year":"2009","unstructured":"Lichtenstein GR, Hanauer SB, Sandborn WJ. Management of Crohn\u2019s disease in adults. Am J Gastroenterol. 2009;104(2):465\u201383.","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"498_CR14","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/ajg.2009.727","volume":"105","author":"A Kornbluth","year":"2010","unstructured":"Kornbluth A, Sachar DB. Ulcerative colitis practice guidelines in adults: American College of Gastroenterology, practice parameters committee. Am J Gastroenterol. 2010;105(3):501\u201323.","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"498_CR15","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/apt.12616","volume":"39","author":"JP Gisbert","year":"2014","unstructured":"Gisbert JP, Chaparro M. Systematic review with meta-analysis: inflammatory bowel disease in the elderly. Aliment Pharmacol Ther. 2014;39(5):459\u201377.","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"498_CR16","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/MCG.0b013e31802f19af","volume":"42","author":"RK Cross","year":"2008","unstructured":"Cross RK, Lapshin O, Finkelstein J. Patient subjective assessment of drug side effects in inflammatory bowel disease. J Clin Gastroenterol. 2008;42(3):244\u201351.","journal-title":"J Clin Gastroenterol"},{"issue":"4","key":"498_CR17","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1053\/j.gastro.2013.12.025","volume":"146","author":"MT Osterman","year":"2014","unstructured":"Osterman MT, Sandborn WJ, Colombel JF, et al. Increased risk of malignancy with adalimumab combination therapy, compared with monotherapy, for Crohn\u2019s disease. Gastroenterology. 2014;146(4):941\u20139.","journal-title":"Gastroenterology"},{"issue":"2","key":"498_CR18","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/ajg.2013.441","volume":"109","author":"GR Lichtenstein","year":"2014","unstructured":"Lichtenstein GR, Feagan BG, Cohen RD, et al. Drug therapies and the risk of malignancy in Crohn\u2019s disease: results from the TREAT\u2122 Registry. Am J Gastroenterol. 2014;109(2):212\u201323.","journal-title":"Am J Gastroenterol"},{"key":"498_CR19","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1001\/jama.2014.5613","volume":"311","author":"AN Nyboe","year":"2014","unstructured":"Nyboe AN, Pasternak B, Basit S, et al. Association between tumor necrosis factor-\u03b1 antagonists and risk of cancer in patients with inflammatory bowel disease. JAMA. 2014;311:2406\u201313.","journal-title":"JAMA"},{"issue":"9","key":"498_CR20","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1136\/gutjnl-2013-305763","volume":"63","author":"L Beaugerie","year":"2014","unstructured":"Beaugerie L, Carrat F, Colombel JF, et al. Risk of new or recurrent cancer under immunosuppressive therapy in patients with IBD and previous cancer. Gut. 2014;63(9):1416\u201323.","journal-title":"Gut"},{"issue":"9","key":"498_CR21","doi-asserted-by":"crossref","first-page":"963","DOI":"10.2217\/imt.14.66","volume":"6","author":"MC Lam","year":"2014","unstructured":"Lam MC, Bressler B. Vedolizumab for ulcerative colitis and Crohn\u2019s disease: results and implications of GEMINI studies. Immunotherapy. 2014;6(9):963\u201371.","journal-title":"Immunotherapy."},{"issue":"12","key":"498_CR22","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1097\/MIB.0000000000000561","volume":"21","author":"E Shelton","year":"2015","unstructured":"Shelton E, Allegretti JR, Stevens B, et al. Efficacy of vedolizumab as induction therapy in refractory IBD patients: a multicenter cohort. Inflamm Bowel Dis. 2015;21(12):2879\u201385.","journal-title":"Inflamm Bowel Dis"},{"issue":"6","key":"498_CR23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11894-015-0444-2","volume":"17","author":"M L\u00f6wenberg","year":"2015","unstructured":"L\u00f6wenberg M, D\u2019Haens G. Next-generation therapeutics for IBD. Curr Gastroenterol Rep. 2015;17(6):1\u20138.","journal-title":"Curr Gastroenterol Rep"},{"issue":"9","key":"498_CR24","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nrgastro.2015.135","volume":"12","author":"S Danese","year":"2015","unstructured":"Danese S, Vuitton L, Peyrin-Biroulet L. Biologic agents for IBD: practical insights. Nat Rev Gastroenterol Hepatol. 2015;12(9):537\u201345.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"10","key":"498_CR25","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1038\/ajg.2016.304","volume":"111","author":"H Cheddani","year":"2016","unstructured":"Cheddani H, Dauchet L, Fumery M, et al. Cancer in elderly onset inflammatory bowel disease: a population-based study. Am J Gastroenterol. 2016;111(10):1428\u201336.","journal-title":"Am J Gastroenterol"},{"issue":"10","key":"498_CR26","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.dld.2016.05.006","volume":"48","author":"S Taleban","year":"2016","unstructured":"Taleban S, Elquza E, Gower-Rousseau C, et al. Cancer and inflammatory bowel disease in the elderly. Dig Liver Dis. 2016;48(10):1105\u201311.","journal-title":"Dig Liver Dis"}],"container-title":["Drugs & Aging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40266-017-0498-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-017-0498-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-017-0498-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,8]],"date-time":"2022-08-08T00:49:33Z","timestamp":1659919773000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40266-017-0498-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":26,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["498"],"URL":"https:\/\/doi.org\/10.1007\/s40266-017-0498-y","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"value":"1170-229X","type":"print"},{"value":"1179-1969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11]]}}}